Cancer Incidence and Mortality among Non-Hispanics, New York City, 2011-2015

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 32444.6 478.5 476.1-480.9 15640.0 528.9 525.2-532.7 16804.6 447.9 444.8-451.0 10191.0 148.1 146.8-149.4 4928.4 174.2 172.0-176.5 5262.6 131.3 129.7-133.0
Oral cavity and pharynx 694.0 10.2 9.9-10.6 454.8 15.0 14.4-15.6 239.2 6.4 6.0-6.8 160.4 2.3 2.2-2.5 111.4 3.7 3.4-4.1 49.0 1.3 1.1-1.4
Esophagus 256.2 3.7 3.5-3.9 182.4 6.2 5.8-6.6 73.8 1.8 1.6-2.0 190.2 2.8 2.6-3.0 132.8 4.6 4.2-4.9 57.4 1.4 1.2-1.6
Stomach 747.4 11.0 10.6-11.3 433.6 15.0 14.3-15.6 313.8 8.0 7.6-8.4 340.0 5.0 4.7-5.2 195.6 6.9 6.5-7.4 144.4 3.6 3.3-3.8
Colorectal 2844.6 41.9 41.2-42.6 1417.6 48.8 47.7-50.0 1427.0 36.7 35.8-37.6 1001.2 14.4 14.0-14.8 478.8 16.9 16.2-17.6 522.4 12.6 12.1-13.1
Colon excluding rectum 2029.6 29.8 29.3-30.4 972.0 33.9 32.9-34.9 1057.6 27.0 26.2-27.7 838.4 12.1 11.7-12.4 392.2 13.9 13.3-14.6 446.2 10.7 10.3-11.2
Rectum & rectosigmoid 815.0 12.0 11.6-12.4 445.6 14.9 14.3-15.6 369.4 9.7 9.3-10.2 162.8 2.4 2.2-2.5 86.6 3.0 2.7-3.3 76.2 1.9 1.7-2.1
Liver / intrahepatic bile duct 732.0 10.4 10.1-10.8 514.2 16.5 15.8-17.2 217.8 5.5 5.2-5.9 460.8 6.6 6.3-6.9 309.2 10.2 9.7-10.8 151.6 3.8 3.5-4.1
Pancreas 993.8 14.4 14.0-14.8 474.6 16.3 15.7-17.0 519.2 13.0 12.5-13.5 772.4 11.2 10.8-11.5 366.2 12.8 12.2-13.4 406.2 10.0 9.5-10.4
Larynx 213.6 3.1 2.9-3.3 171.4 5.7 5.3-6.1 42.2 1.1 0.9-1.2 69.6 1.0 0.9-1.1 53.2 1.8 1.6-2.1 16.4 0.4 0.3-0.5
Lung and bronchus 3653.6 53.5 52.7-54.3 1837.0 63.7 62.4-65.1 1816.6 46.5 45.5-47.5 2293.8 33.4 32.8-34.0 1218.0 42.8 41.7-43.9 1075.8 26.9 26.1-27.6
Melanoma of the skin 878.6 13.0 12.6-13.4 479.6 16.6 16.0-17.3 399.0 10.6 10.1-11.1 97.2 1.4 1.3-1.5 56.0 2.0 1.7-2.2 41.2 1.0 0.9-1.2
Female breast             4775.6 130.8 129.1-132.5             848.4 21.7 21.0-22.3
Cervix uteri             315.0 9.1 8.6-9.5             104.4 2.8 2.6-3.1
Corpus uterus and NOS             1260.4 32.7 31.9-33.5             279.6 7.0 6.6-7.4
Ovary             481.4 12.9 12.4-13.5             285.4 7.3 6.9-7.7
Prostate       4220.8 136.1 134.2-138.0             552.6 20.7 19.9-21.5      
Testis       155.8 5.1 4.8-5.5             4.8 0.2 0.1-0.2      
Urinary bladder (incl. in situ) 1288.8 18.9 18.4-19.3 947.6 33.8 32.8-34.8 341.2 8.5 8.1-8.9 273.2 3.9 3.7-4.1 181.2 6.7 6.3-7.2 92.0 2.1 1.9-2.3
Kidney and renal pelvis 1011.6 15.0 14.5-15.4 646.6 21.5 20.7-22.3 365.0 9.7 9.3-10.2 186.8 2.7 2.5-2.9 116.6 4.0 3.7-4.4 70.2 1.7 1.5-1.9
Brain and other nervous system 393.4 6.2 5.9-6.5 208.8 7.3 6.8-7.7 184.6 5.3 5.0-5.7 214.6 3.2 3.0-3.4 109.0 3.7 3.4-4.1 105.6 2.8 2.6-3.1
Thyroid 1463.8 22.7 22.1-23.2 353.8 11.8 11.2-12.3 1110.0 32.4 31.6-33.3 39.8 0.6 0.5-0.7 14.2 0.5 0.4-0.6 25.6 0.6 0.5-0.7
Hodgkin lymphoma 202.8 3.3 3.1-3.5 105.6 3.6 3.3-3.9 97.2 2.9 2.7-3.2 23.2 0.4 0.3-0.4 12.0 0.4 0.3-0.5 11.2 0.3 0.2-0.4
Non-Hodgkin lymphomas 1394.0 20.8 20.3-21.3 742.2 25.6 24.8-26.5 651.8 17.1 16.5-17.7 339.0 4.9 4.7-5.2 180.8 6.5 6.0-6.9 158.2 3.9 3.6-4.2
Myeloma 617.4 9.0 8.7-9.4 327.4 11.2 10.7-11.8 290.0 7.5 7.1-7.9 204.4 3.0 2.8-3.2 103.6 3.7 3.3-4.0 100.8 2.5 2.3-2.7
Leukemias 976.6 14.7 14.3-15.2 540.8 19.0 18.3-19.7 435.8 11.7 11.2-12.2 385.6 5.7 5.5-6.0 214.4 7.8 7.3-8.3 171.2 4.3 4.0-4.6

Notes

  • Incidence data are provisional, November 2017.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.